UNSPSC 51101602: Eflornithine

This classification denotes an ornithine decarboxylase inhibitor with the molecular formula C6H12F2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZQN1G5V6SR, chemically known as 2,5-diamino-2-(difluoromethyl)pentanoic acid but generally known as eflornithine, which bears US NIH Compound Identifier 3009. European Medicines Agency schedules Eflornithine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06468MIG.

UNSPSC 51101602 Eflornithine (Commodity) represents pharmaceutical products that state and local health agencies procure through cooperative purchasing vehicles and competitive bidding. Recent activity shows state and local governments buying pharmaceutical supplies — including antimicrobial tablets, naloxone, and drug deactivation systems — via piggyback contracts and direct procurement to support public health initiatives, emergency response, and community health programs. Issuing bodies include state departments of public health and county health authorities. The Illinois Department of Public Health and Seminole County, Florida appear as recent buyers, with Illinois leveraging the MMCAP Infuse cooperative consortium for pharmaceutical warehouse orders and Seminole County procuring naloxone and drug deactivation systems through competitive IFB.

Activity concentrates in Illinois and Florida based on recent postings. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract to Chartwell Rx LLC on August 28, 2026, through MMCAP Infuse for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets totaling $2,999,999.11 over a 12-month initial term with two renewal options; the award followed an IFB process completed on or before September 11, 2026. Seminole County, Florida issued an IFB on June 30, 2026, for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023, and potential FEMA funding. Both opportunities reflect state and local reliance on cooperative purchasing and fixed-price contracts for pharmaceutical supply chain management.